Medical - Healthcare Information Services
Compare Stocks
5 / 10Stock Comparison
HCTI vs MTEX vs HIMS vs AMZN vs MSFT
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Medical - Equipment & Services
Specialty Retail
Software - Infrastructure
HCTI vs MTEX vs HIMS vs AMZN vs MSFT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Household & Personal Products | Medical - Equipment & Services | Specialty Retail | Software - Infrastructure |
| Market Cap | $49K | $9M | $6.63B | $2.92T | $3.13T |
| Revenue (TTM) | $13M | $110M | $2.35B | $742.78B | $318.27B |
| Net Income (TTM) | $-6M | $-2M | $128M | $90.80B | $125.22B |
| Gross Margin | 13.1% | 75.1% | 69.7% | 50.6% | 68.3% |
| Operating Margin | -45.2% | 0.5% | 4.6% | 11.5% | 46.8% |
| Forward P/E | — | 3.5x | 51.5x | 34.8x | 25.3x |
| Total Debt | $3M | $7M | $1.12B | $152.99B | $112.18B |
| Cash & Equiv. | $20K | $11M | $229M | $86.81B | $30.24B |
HCTI vs MTEX vs HIMS vs AMZN vs MSFT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Healthcare Triangle… (HCTI) | 100 | 0.0 | -100.0% |
| Mannatech, Incorpor… (MTEX) | 100 | 11.5 | -88.5% |
| Hims & Hers Health,… (HIMS) | 100 | 329.0 | +229.0% |
| Amazon.com, Inc. (AMZN) | 100 | 160.8 | +60.8% |
| Microsoft Corporati… (MSFT) | 100 | 126.9 | +26.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCTI vs MTEX vs HIMS vs AMZN vs MSFT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, HCTI doesn't own a clear edge in any measured category.
MTEX is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 0.27, current ratio 1.25x
- Lower P/E (3.5x vs 25.3x)
- Beta 0.27 vs HCTI's 3.07
HIMS ranks third and is worth considering specifically for growth exposure.
- Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
- 59.0% revenue growth vs HCTI's -64.8%
AMZN is the clearest fit if your priority is valuation efficiency.
- PEG 1.24 vs MSFT's 1.35
- +43.7% vs HCTI's -99.9%
MSFT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 19 yrs, beta 0.89, yield 0.8%
- 7.9% 10Y total return vs HIMS's 161.9%
- Lower volatility, beta 0.89, Low D/E 32.7%, current ratio 1.35x
- 39.3% margin vs HCTI's -48.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs HCTI's -64.8% | |
| Value | Lower P/E (3.5x vs 25.3x) | |
| Quality / Margins | 39.3% margin vs HCTI's -48.9% | |
| Stability / Safety | Beta 0.27 vs HCTI's 3.07 | |
| Dividends | 0.8% yield; 19-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +43.7% vs HCTI's -99.9% | |
| Efficiency (ROA) | 19.2% ROA vs HCTI's -60.0%, ROIC 24.9% vs -6.3% |
HCTI vs MTEX vs HIMS vs AMZN vs MSFT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HCTI vs MTEX vs HIMS vs AMZN vs MSFT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSFT leads in 3 of 6 categories
MTEX leads 1 • AMZN leads 1 • HCTI leads 0 • HIMS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSFT leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 57397.1x HCTI's $13M. MSFT is the more profitable business, keeping 39.3% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, HCTI holds the edge at +44.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $110M | $2.3B | $742.8B | $318.3B |
| EBITDAEarnings before interest/tax | -$6M | $2M | $164M | $155.9B | $192.6B |
| Net IncomeAfter-tax profit | -$6M | -$2M | $128M | $90.8B | $125.2B |
| Free Cash FlowCash after capex | -$12M | -$4M | $73M | -$2.5B | $72.9B |
| Gross MarginGross profit ÷ Revenue | +13.1% | +75.1% | +69.7% | +50.6% | +68.3% |
| Operating MarginEBIT ÷ Revenue | -45.2% | +0.5% | +4.6% | +11.5% | +46.8% |
| Net MarginNet income ÷ Revenue | -48.9% | -1.5% | +5.5% | +12.2% | +39.3% |
| FCF MarginFCF ÷ Revenue | -94.7% | -3.6% | +3.1% | -0.3% | +22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +44.6% | -8.1% | +28.4% | +16.6% | +18.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -63.8% | +6.9% | -27.3% | +74.8% | +23.4% |
Valuation Metrics
MTEX leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 3.5x trailing earnings, MTEX trades at a 93% valuation discount to HIMS's 50.3x P/E. Adjusting for growth (PEG ratio), AMZN offers better value at 1.35x vs MSFT's 1.64x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $49,177 | $9M | $6.6B | $2.92T | $3.13T |
| Enterprise ValueMkt cap + debt − cash | $3M | $4M | $7.5B | $2.98T | $3.21T |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 3.54x | 50.32x | 37.82x | 30.86x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 51.51x | 34.77x | 25.34x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.35x | 1.64x |
| EV / EBITDAEnterprise value multiple | — | 1.41x | 42.68x | 20.47x | 19.72x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 0.08x | 2.82x | 4.07x | 11.10x |
| Price / BookPrice ÷ Book value/share | — | 1.02x | 12.25x | 7.14x | 9.15x |
| Price / FCFMarket cap ÷ FCF | — | 4.52x | 89.61x | 378.98x | 43.66x |
Profitability & Efficiency
MSFT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
MSFT delivers a 33.1% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $-113 for HCTI. MSFT carries lower financial leverage with a 0.33x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIMS's 2.07x. On the Piotroski fundamental quality scale (0–9), AMZN scores 6/9 vs HCTI's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -112.9% | -23.8% | +23.7% | +23.3% | +33.1% |
| ROA (TTM)Return on assets | -60.0% | -4.9% | +6.0% | +11.5% | +19.2% |
| ROICReturn on invested capital | -6.3% | +17.3% | +10.7% | +14.7% | +24.9% |
| ROCEReturn on capital employed | — | +9.3% | +10.9% | +15.3% | +29.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 4 | 6 | 6 |
| Debt / EquityFinancial leverage | — | 0.78x | 2.07x | 0.37x | 0.33x |
| Net DebtTotal debt minus cash | $3M | -$5M | $892M | $66.2B | $81.9B |
| Cash & Equiv.Liquid assets | $20,000 | $11M | $229M | $86.8B | $30.2B |
| Total DebtShort + long-term debt | $3M | $7M | $1.1B | $153.0B | $112.2B |
| Interest CoverageEBIT ÷ Interest expense | -3.79x | 0.38x | — | 39.96x | 55.65x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, AMZN leads with a +43.7% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs HCTI's -96.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -93.7% | -44.1% | -23.2% | +19.7% | -10.8% |
| 1-Year ReturnPast 12 months | -99.9% | -53.3% | -51.0% | +43.7% | -2.1% |
| 3-Year ReturnCumulative with dividends | -100.0% | -63.8% | +116.6% | +156.2% | +39.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | -61.0% | +137.6% | +64.8% | +72.5% |
| 10-Year ReturnCumulative with dividends | -100.0% | -35.2% | +161.9% | +697.8% | +787.7% |
| CAGR (3Y)Annualised 3-year return | -96.0% | -28.8% | +29.4% | +36.8% | +11.7% |
Risk & Volatility
Evenly matched — MTEX and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MTEX is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than HCTI's 3.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.07x | 0.27x | 2.40x | 1.51x | 0.89x |
| 52-Week HighHighest price in past year | $7410.00 | $12.45 | $70.43 | $278.56 | $555.45 |
| 52-Week LowLowest price in past year | $0.29 | $4.20 | $13.74 | $185.01 | $356.28 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +37.5% | +36.4% | +97.3% | +75.8% |
| RSI (14)Momentum oscillator 0–100 | 36.7 | 43.6 | 54.5 | 81.1 | 54.0 |
| Avg Volume (50D)Average daily shares traded | 572K | 10K | 34.9M | 45.5M | 32.5M |
Analyst Outlook
MSFT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: HIMS as "Hold", AMZN as "Buy", MSFT as "Buy". Consensus price targets imply 31.1% upside for MSFT (target: $552) vs 13.1% for AMZN (target: $307). MSFT is the only dividend payer here at 0.77% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $29.67 | $306.77 | $551.75 |
| # AnalystsCovering analysts | — | — | 19 | 94 | 81 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | 0 | — | — | 19 |
| Dividend / ShareAnnual DPS | — | — | — | — | $3.23 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.4% | 0.0% | +0.6% |
MSFT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MTEX leads in 1 (Valuation Metrics). 1 tied.
HCTI vs MTEX vs HIMS vs AMZN vs MSFT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HCTI or MTEX or HIMS or AMZN or MSFT a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Mannatech, Incorporated (MTEX) offers the better valuation at 3. 5x trailing P/E, making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCTI or MTEX or HIMS or AMZN or MSFT?
On trailing P/E, Mannatech, Incorporated (MTEX) is the cheapest at 3.
5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Microsoft Corporation is actually cheaper at 25. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Amazon. com, Inc. wins at 1. 24x versus Microsoft Corporation's 1. 35x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — HCTI or MTEX or HIMS or AMZN or MSFT?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +137. 6%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: MSFT returned +787. 7% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCTI or MTEX or HIMS or AMZN or MSFT?
By beta (market sensitivity over 5 years), Mannatech, Incorporated (MTEX) is the lower-risk stock at 0.
27β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 1047% more volatile than MTEX relative to the S&P 500. On balance sheet safety, Microsoft Corporation (MSFT) carries a lower debt/equity ratio of 33% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HCTI or MTEX or HIMS or AMZN or MSFT?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Mannatech, Incorporated grew EPS 210. 0% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCTI or MTEX or HIMS or AMZN or MSFT?
Microsoft Corporation (MSFT) is the more profitable company, earning 36.
1% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 36. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSFT leads at 45. 6% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — MTEX leads at 77. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCTI or MTEX or HIMS or AMZN or MSFT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Amazon. com, Inc. (AMZN) is the more undervalued stock at a PEG of 1. 24x versus Microsoft Corporation's 1. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Microsoft Corporation (MSFT) trades at 25. 3x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 26. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MSFT: 31. 1% to $551. 75.
08Which pays a better dividend — HCTI or MTEX or HIMS or AMZN or MSFT?
In this comparison, MSFT (0.
8% yield) pays a dividend. HCTI, MTEX, HIMS, AMZN do not pay a meaningful dividend and should not be held primarily for income.
09Is HCTI or MTEX or HIMS or AMZN or MSFT better for a retirement portfolio?
For long-horizon retirement investors, Microsoft Corporation (MSFT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
89), 0. 8% yield, +787. 7% 10Y return). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MSFT: +787. 7%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCTI and MTEX and HIMS and AMZN and MSFT?
These companies operate in different sectors (HCTI (Healthcare) and MTEX (Consumer Defensive) and HIMS (Healthcare) and AMZN (Consumer Cyclical) and MSFT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCTI is a small-cap quality compounder stock; MTEX is a small-cap deep-value stock; HIMS is a small-cap high-growth stock; AMZN is a mega-cap quality compounder stock; MSFT is a mega-cap quality compounder stock. MSFT pays a dividend while HCTI, MTEX, HIMS, AMZN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.